• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

siRNA

Glowing puzzle piece fitting into puzzle
Biotech

Alnylam pays Inceptive $30M to transform siRNA design

Alnylam has partnered with the person who helped put the “T” in ChatGPT, paying $30 million to work with Inceptive Nucleics on AI-enabled drug design.
Nick Paul Taylor Jun 4, 2026 4:13am
AstraZeneca booth at AACR 2026

AstraZeneca FLAP inhibitor flunks ph. 2 asthma trial

Apr 29, 2026 8:38am
Statue in Vienna of Heracles battling the hydra

The 'diabolical' molecule set to become biotech's next gold rush

Apr 9, 2026 8:00am
big wave over ship in storm

Wave crashes after obesity trial tracks 1% dip in body weight

Mar 26, 2026 9:20am
Completing steps towards success checkmark on cubes symbolizing progress

Sarepta's big bet on Arrowhead's siRNA assets yields early data

Mar 25, 2026 9:35am
phoenix rising from the flames

Atrium arises from Avidity buyout with $270M, preclinical assets

Feb 27, 2026 11:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
Âİ2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings